by
In this discussion, Dr. Robert Malenka, a leading neurobiologist at Stanford, unpacks how our brain's reward systems drive choices. He dives into the roles of dopamine and serotonin in behavior, motivation, and social connections. Malenka elucidates the impact of neuroplasticity on addiction and how context can hijack reward systems. He also explores empathy's biological roots and the potential therapeutic effects of substances like MDMA on social behavior and autism, shedding light on the fascinating interplay between neuroscience and our daily choices.
Dopamine is a major neuromodulator that signals salience—not just pleasure. Ventral tegmental area (VTA) dopamine neurons project to the nucleus accumbens, linking arousal, attention, and memory to things that matter for survival (food, sex, danger).
It’s evolution’s way of saying: remember this.
...there's something really important happening in our environment.
— Robert Malenka
The reward circuitry is highly plastic and context-dependent. A smell can trigger craving in the morning and aversion later the same day—because hippocampus, amygdala and prefrontal inputs reshape responses.
The accumbens integrates memories, emotion, and rules to scale whether a cue increases or decreases a behavior’s probability.
Addictive liability depends on how much dopamine is released and how fast. Rapid delivery (smoking/injecting) causes intense, short surges that strongly reinforce repetition. Drugs also change synapses—sometimes after a single dose—so experience + genetics + environment determine risk.
I hate it, but I want to do it again.
— Recovered user (described by Malenka)
Pro‑social interactions activate reward circuitry. Oxytocin, serotonin and dopamine interact in complex ways: oxytocin can modulate VTA dopamine, serotonin in the nucleus accumbens promotes sociability, and their balance shapes social reinforcement.
This wiring explains pair‑bonding findings in voles and why social connection feels deeply rewarding.
Malenka’s lab developed assays showing mice mirror others’ states: a bystander mouse shows pain after an hour with a hurt peer, and a mouse in pain gains analgesia after hanging out with a relieved companion. These behaviors map to anterior cingulate → accumbens pathways, linking empathy to reward circuits.
MDMA boosts both serotonin and dopamine, but its pro‑social effects appear tied to serotonin in the accumbens, while its reinforcing/addictive aspects involve dopamine. This makes MDMA a unique probe for social behavior and a candidate (with caution) for therapies targeting social deficits like some autism presentations.